retatrutide triple hormone receptor agonist weight loss Medscape | Retatrutide, Eli Lilly's first-in-class agonist, delivered meaningful at 80 weeks in all doses in the Retatrutide: A Triple Agonist Shaping
Pay in 4 interest-free payments of $6.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 18 - Nov 23



























